Abstract

Review Article

Harnessing the Power of Artificial Intelligence in the Fight against COVID-19: A Comprehensive Review

Dasaradharami Reddy K*, Anusha S, Ashalatha N and Mohammed Azharuddin Ahmed

Published: 30 September, 2026 | Volume 9 - Issue 1 | Pages: 61-79

The COVID-19 pandemic accelerated the development and application of artificial intelligence (AI) across disease surveillance, epidemiological forecasting, medical imaging, prognosis, drug discovery, vaccine research, contact tracing, and public-health decision support. This review synthesizes the literature on these applications while critically examining the evidence needed for translation into clinical and public-health practice. A structured literature-search and selection framework was used to organize evidence published from the emergence of COVID-19 through the contemporary literature, with emphasis on peer-reviewed studies and recent reviews. The evidence was synthesized according to the pandemic-response pathway: early warning and surveillance; diagnosis and differential diagnosis; severity and prognosis; clinical and resource decision support; therapeutic and vaccine discovery; genomic surveillance; and privacy-preserving and responsible AI. Across these domains, AI demonstrates potential to process heterogeneous data and support time-sensitive decisions, but reported performance does not by itself establish clinical utility. Recurring limitations include small or non-representative datasets, dataset shift, limited external validation, class imbalance, information leakage, insufficient calibration and interpretability, privacy and security risks, and uncertainty about workflow integration and regulatory accountability. Recent systematic reviews also indicate that multimodal, federated, and privacy-preserving approaches remain less developed than conventional centralized models. The principal contribution of this review is a unified critical framework that links technical performance with data quality, external validation, clinical relevance, fairness, privacy, interpretability, and implementation readiness. The review therefore identifies not only where AI has been applied to COVID-19, but also the conditions required for responsible translation to clinical practice and future pandemic preparedness.

Read Full Article HTML DOI: 10.29328/journal.ijcmbt.1001042 Cite this Article Read Full Article PDF

Keywords:

COVID-19; SARS-CoV-2; Artificial intelligence; Machine learning; Deep learning; Diagnosis, prognosis; Epidemiological forecasting, drug discovery; Responsible AI

References

  1. Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy. 2020;5:1-3. Available from: https://doi.org/10.1186/s41256-020-00135-6
  2. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. 2020.
  3. Almaghaslah D, Kandasamy G, Almanasef M, Vasudevan R, Chandramohan S. Review on the coronavirus disease (COVID‐19) pandemic: its outbreak and current status. Int J Clin Pract. 2020;74(11):e13637. Available from: https://doi.org/10.1111/ijcp.13637
  4. Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021;375. Available from: https://doi.org/10.1136/bmj-2021-068302
  5. da Silva RGL, Chammas R, Novaes HMD. Rethinking approaches of science, technology, and innovation in healthcare during the COVID-19 pandemic: the challenge of translating knowledge infrastructures to public needs. Health Res Policy Syst. 2021;19(1):1-9. Available from: https://doi.org/10.1186/s12961-021-00760-8
  6. Chen J, Li K, Zhang Z, Li K, Yu PS. A survey on applications of artificial intelligence in fighting against COVID-19. ACM Comput Surv. 2021;54(8):1-32.
  7. Agbehadji IE, Awuzie BO, Ngowi AB, Millham RC. Review of big data analytics, artificial intelligence and nature-inspired computing models towards accurate detection of COVID-19 pandemic cases and contact tracing. Int J Environ Res Public Health. 2020;17(15):5330. Available from: https://doi.org/10.3390/ijerph17155330
  8. Wang S, Kang B, Ma J, Zeng X, Xiao M, Guo J, et al. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). Eur Radiol. 2021;31:6096-104. Available from: https://doi.org/10.1007/s00330-021-07715-1
  9. Shorten C, Khoshgoftaar TM, Furht B. Deep Learning applications for COVID-19. J Big Data. 2021;8(1):1-54. Available from: https://doi.org/10.1186/s40537-020-00392-9
  10. Khan M, Mehran MT, Haq ZU, Ullah Z, Naqvi SR, Ihsan M, Abbass H. Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Expert Syst Appl. 2021;185:115695. Available from: https://doi.org/10.1016/j.eswa.2021.115695
  11. Wang XV, Wang L. A literature survey of the robotic technologies during the COVID-19 pandemic. J Manuf Syst. 2021;60:823-36. Available from: https://doi.org/10.1016/j.jmsy.2021.02.005
  12. Bajwa J, Munir U, Nori A, Williams B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Healthc J. 2021;8(2):e188. Available from: https://doi.org/10.7861/fhj.2021-0095
  13. Pham QV, Nguyen DC, Huynh-The T, Hwang WJ, Pathirana PN. Artificial intelligence (AI) and big data for coronavirus (COVID-19) pandemic: a survey on the state-of-the-arts. IEEE Access. 2020;8:130820-39. Available from: https://doi.org/10.1109/access.2020.3009328
  14. Rasheed J, Jamil A, Hameed AA, Al-Turjman F, Rasheed A. COVID-19 in the age of artificial intelligence: a comprehensive review. Interdiscip Sci Comput Life Sci. 2021;13:153-75. Available from: https://doi.org/10.1007/s12539-021-00431-w
  15. Bansal A, Padappayil RP, Garg C, Singal A, Gupta M, Klein A. Utility of artificial intelligence amidst the COVID-19 pandemic: a review. J Med Syst. 2020;44:1-6. Available from: https://doi.org/10.1007/s10916-020-01617-3
  16. Rahimi I, Gandomi AH, Asteris PG, Chen F. Analysis and prediction of COVID-19 Using SIR, SEIQR, and machine learning models: Australia, Italy, and UK Cases. Information. 2021;12(3):109.
  17. Kumar S, Raut RD, Narkhede BE. A proposed collaborative framework by using artificial intelligence-internet of things (AI-IoT) in COVID-19 pandemic situation for healthcare workers. Int J Healthc Manag. 2020;13(4):337-45.
  18. Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):e30-1. Available from: https://doi.org/10.1016/s0140-6736(20)30304-4
  19. Jamshidi M, Roshani S, Talla J, Lalbakhsh A, Peroutka Z, Roshani S, et al. A review on potentials of artificial intelligence approaches to forecasting COVID-19 spreading. Preprint. 2021.
  20. Salgotra R, Gandomi M, Gandomi AH. Evolutionary modelling of the COVID-19 pandemic in fifteen most affected countries. Chaos Solitons Fractals. 2020;140:110118.
  21. Shinde GR, Kalamkar AB, Mahalle PN, Dey N, Chaki J, Hassanien AE. Forecasting models for coronavirus disease (COVID-19): a survey of the state-of-the-art. SN Comput Sci. 2020;1:1-15.
  22. Albahri OS, Zaidan AA, Albahri AS, Zaidan BB, Abdulkareem KH, Al-Qaysi ZT, et al. Systematic review of artificial intelligence techniques in the detection and classification of COVID-19 medical images in terms of evaluation and benchmarking: taxonomy analysis, challenges, future solutions and methodological aspects. J Infect Public Health. 2020;13(10):1381-96.
  23. Ahmad F, Almuayqil SN, Humayun M, Naseem S, Khan WA, Junaid K. Prediction of COVID-19 cases using machine learning for effective public health management. Comput Mater Contin. 2021;66:2265-82.
  24. Monshi MMA, Poon J, Chung V. Deep learning in generating radiology reports: a survey. Artif Intell Med. 2020;106:101878.
  25. Jalaber C, Lapotre T, Morcet-Delattre T, Ribet F, Jouneau S, Lederlin M. Chest CT in COVID-19 pneumonia: a review of current knowledge. Diagn Interv Imaging. 2020;101(7-8):431-7.
  26. Dong J, Wu H, Zhou D, Li K, Zhang Y, Ji H, et al. Application of big data and artificial intelligence in COVID-19 prevention, diagnosis, treatment and management decisions in China. J Med Syst. 2021;45(9):84.
  27. Asteris PG, Gavriilaki E, Touloumenidou T, Koravou EE, Koutra M, Papayanni PG, et al. Genetic prediction of ICU hospitalization and mortality in COVID-19 patients using artificial neural networks. J Cell Mol Med. 2022;26(5):1445-55.
  28. Shi F, Wang J, Shi J, Wu Z, Wang Q, Tang Z, et al. Review of artificial intelligence techniques in imaging data acquisition, segmentation, and diagnosis for COVID-19. IEEE Rev Biomed Eng. 2020;14:4-15.
  29. Merkoçi A, Li CZ, Lechuga LM, Ozcan A. COVID-19 biosensing technologies. Biosens Bioelectron. 2021;178:113046.
  30. Maheshwari V, Mahmood MR, Sravanthi S, Arivazhagan N, ParimalaGandhi A, Srihari K, et al. Nanotechnology-based sensitive biosensors for COVID-19 prediction using fuzzy logic control. J Nanomater. 2021;2021:1-8.
  31. Gudigar A, Raghavendra U, Nayak S, Ooi CP, Chan WY, Gangavarapu MR, et al. Role of artificial intelligence in COVID-19 detection. Sensors. 2021;21(23):8045.
  32. Anjaria P, Asediya V, Bhavsar P, Pathak A, Desai D, Patil V. Artificial intelligence in public health: revolutionizing epidemiological surveillance for pandemic preparedness and equitable vaccine access. Vaccines (Basel). 2023;11(7):1154.
  33. Piccialli F, Di Cola VS, Giampaolo F, Cuomo S. The role of artificial intelligence in fighting the COVID-19 pandemic. Inf Syst Front. 2021;23(6):1467-97.
  34. Liang H, Tsui BY, Ni H, Valentim CC, Baxter SL, Liu G, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nat Med. 2019;25(3):433-8.
  35. Bragazzi NL, Dai H, Damiani G, Behzadifar M, Martini M, Wu J. How big data and artificial intelligence can help better manage the COVID-19 pandemic. Int J Environ Res Public Health. 2020;17(9):3176.
  36. Behura A. The cluster analysis and feature selection: perspective of machine learning and image processing. In: Data Analytics in Bioinformatics: A Machine Learning Perspective. 2021. p. 249-80.
  37. Rehman SU, Shafqat F, Niaz K. Recent artificial intelligence methods and coronaviruses. In: Application of Natural Products in SARS-CoV-2. Academic Press; 2023. p. 353-80.
  38. Sharma PD, Rallapalli S, Lakkaniga NR. An innovative approach for predicting pandemic hotspots in complex wastewater networks using graph theory coupled with fuzzy logic. Stoch Environ Res Risk Assess. 2023:1-18.
  39. Fong SJ, Dey N, Chaki J. Artificial intelligence for coronavirus outbreak. Springer. 2021.
  40. Arora N, Banerjee AK, Narasu ML. The role of artificial intelligence in tackling COVID-19. Future Virol. 2020;15(11):717-24.
  41. Khan AI, Shah JL, Bhat MM. CoroNet: a deep neural network for detection and diagnosis of COVID-19 from chest x-ray images. Comput Methods Programs Biomed. 2020;196:105581.
  42. Delli Pizzi A, Chiarelli AM, Chiacchiaretta P, Valdesi C, Croce P, Mastrodicasa D, et al. Radiomics-based machine learning differentiates “ground-glass” opacities due to COVID-19 from acute non-COVID-19 lung disease. Sci Rep. 2021;11(1):17237.
  43. Arora G, Joshi J, Mandal RS, Shrivastava N, Virmani R, Sethi T. Artificial intelligence in surveillance, diagnosis, drug discovery and vaccine development against COVID-19. Pathogens. 2021;10(8):1048.
  44. Nawaz MS, Fournier-Viger P, Shojaee A, Fujita H. Using artificial intelligence techniques for COVID-19 genome analysis. Appl Intell. 2021;51:3086-103.
  45. Jain A, Tiwari S. Prediction and visualisation of viral genome antigen using deep learning & artificial intelligence. In: 2021 5th International Conference on Computing Methodologies and Communication (ICCMC). IEEE; 2021. p. 1430-7.
  46. Zhou Y, Wang F, Tang J, Nussinov R, Cheng F. Artificial intelligence in COVID-19 drug repurposing. Lancet Digit Health. 2020;2(12):e667-76.
  47. Yuvaraj N, Srihari K, Chandragandhi S, Raja RA, Dhiman G, Kaur A. Analysis of protein-ligand interactions of SARS-CoV-2 against selective drug using deep neural networks. Big Data Min Anal. 2021;4(2):76-83.
  48. Nayak SS, Naidu A, Sudhakaran SL, Vino S, Selvaraj G. Prospects of novel and repurposed immunomodulatory drugs against acute respiratory distress syndrome (ARDS) associated with COVID-19 disease. J Pers Med. 2023;13(4):664.
  49. Bhattamisra SK, Banerjee P, Gupta P, Mayuren J, Patra S, Candasamy M. Artificial intelligence in pharmaceutical and healthcare research. Big Data Cogn Comput. 2023;7(1):10.
  50. Alowais SA, Alghamdi SS, Alsuhebany N, Alqahtani T, Alshaya AI, Almohareb SN, et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023;23(1):689.
  51. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385-91.
  52. Kersloot MG, van Putten FJ, Abu-Hanna A, Cornet R, Arts DL. Natural language processing algorithms for mapping clinical text fragments onto ontology concepts: a systematic review and recommendations for future studies. J Biomed Semantics. 2020;11:1-21.
  53. Rodríguez-Gascón A, Solinís MÁ, Isla A. The role of PK/PD analysis in the development and evaluation of antimicrobials. Pharmaceutics. 2021;13(6):833.
  54. Prasad K, Kumar V. Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2. Curr Res Pharmacol Drug Discov. 2021;2:100042.
  55. Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916.
  56. Ahmed I, Jeon G. Enabling artificial intelligence for genome sequence analysis of COVID-19 and alike viruses. Interdiscip Sci Comput Life Sci. 2022;14(2):504-19.
  57. Bhat S, Pandey A, Kanakan A, Maurya R, Vasudevan JS, Devi P, et al. Learning from biological and computational machines: importance of SARS-CoV-2 genomic surveillance, mutations and risk stratification. Front Cell Infect Microbiol. 2021;11:1293.
  58. Dasaradharami Reddy K, Gadekallu TR. A comprehensive survey on federated learning techniques for healthcare informatics. Comput Intell Neurosci. 2023;2023.
  59. Pereira IG, Junior AGDS, Aragão DP, de Oliveira EV, Bezerra AA, Pereira FDA, et al. Epidemiology forecasting of COVID-19 using AI—a survey. In: Computational Intelligence for COVID-19 and Future Pandemics: Emerging Applications and Strategies. 2022. p. 89-120.
  60. Ueda D, Kakinuma T, Fujita S, Kamagata K, Fushimi Y, Ito R, et al. Fairness of artificial intelligence in healthcare: review and recommendations. Jpn J Radiol. 2023:1-13.
  61. Patil R, Dave R, Patel H, Shah VM, Chakrabarti D, Bhatia U. Assessing the interplay between travel patterns and SARS-CoV-2 outbreak in realistic urban setting. Appl Netw Sci. 2021;6:1-19.
  62. Pillai SV, Kumar RS. The role of data-driven artificial intelligence on COVID-19 disease management in public sphere: a review. Decision. 2021;48:375-89.
  63. Ortiz-Barrios M, Arias-Fonseca S, Ishizaka A, Barbati M, Avendaño-Collante B, Navarro-Jiménez E. Artificial intelligence and discrete-event simulation for capacity management of intensive care units during the Covid-19 pandemic: a case study. J Bus Res. 2023;160:113806.
  64. Syrowatka A, Kuznetsova M, Alsubai A, Beckman AL, Bain PA, Craig KJT, et al. Leveraging artificial intelligence for pandemic preparedness and response: a scoping review to identify key use cases. NPJ Digit Med. 2021;4(1):96.
  65. Xu Z, Su C, Xiao Y, Wang F. Artificial intelligence for COVID-19: battling the pandemic with computational intelligence. Intell Med. 2022;2(1):13-29.
  66. Arık SÖ, Shor J, Sinha R, Yoon J, Ledsam JR, Le LT, et al. A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan. NPJ Digit Med. 2021;4(1):146.
  67. Yuan M, Liu T, Yang C. Exploring the relationship among human activities, COVID-19 morbidity, and at-risk areas using location-based social media data: knowledge about the early pandemic stage in Wuhan. Int J Environ Res Public Health. 2022;19(11):6523.
  68. Laventhal N, Basak R, Dell ML, Diekema D, Elster N, Geis G, et al. The ethics of creating a resource allocation strategy during the COVID-19 pandemic. Pediatrics. 2020;146(1).
  69. Aldoseri A, Al-Khalifa KN, Hamouda AM. Re-thinking data strategy and integration for artificial intelligence: concepts, opportunities, and challenges. Appl Sci. 2023;13(12):7082.
  70. Rodrigues CM, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020;11:1526.
  71. Wang Y, Shi M, Zhang J. What public health campaigns can learn from people’s Twitter reactions on mask-wearing and COVID-19 vaccines: a topic modeling approach. Cogent Soc Sci. 2021;7(1):1959728.
  72. El-Bouzaidi YEI, Abdoun O. Advances in artificial intelligence for accurate and timely diagnosis of COVID-19: a comprehensive review of medical imaging analysis. Sci Afr. 2023:e01961.
  73. Jin S, Liu G, Bai Q. Deep learning in COVID-19 diagnosis, prognosis and treatment selection. Mathematics. 2023;11(6):1279.
  74. Fusco R, Grassi R, Granata V, Setola SV, Grassi F, Cozzi D, et al. Artificial intelligence and COVID-19 using chest CT scan and chest X-ray images: machine learning and deep learning approaches for diagnosis and treatment. J Pers Med. 2021;11(10):993.
  75. Lv C, Guo W, Yin X, Liu L, Huang X, Li S, Zhang L. Innovative applications of artificial intelligence during the COVID-19 pandemic. Infect Med. 2024;3(1):100095. Available from: https://dx.doi.org/ 10.1016/j.imj.2024.100095  
  76. Zhang K, Liu X, Shen J, Li Z, Sang Y, Wu X, et al. Clinically applicable AI system for accurate diagnosis, quantitative measurements, and prognosis of COVID-19 pneumonia using computed tomography. Cell. 2020;181(6):1423-33.
  77. Dangeti A, Bynagari DG, Vydani K. Revolutionizing drug formulation: harnessing artificial intelligence and machine learning for enhanced stability, formulation optimization, and accelerated development. 2023.
  78. Li X, Zhou M, Wu J, Yuan A, Wu F, Li J. Analyzing COVID-19 on online social media: trends, sentiments and emotions. arXiv [Preprint]. 2020. Available from: arXiv:2005.14464.
  79. Benis A, Chatsubi A, Levner E, Ashkenazi S. Change in threads on Twitter regarding influenza, vaccines, and vaccination during the COVID-19 pandemic: artificial intelligence–based infodemiology study. JMIR Infodemiology. 2021;1(1):e31983.
  80. Mir SA, Bhat MS, Rather GM, Mattoo D. Role of big geospatial data in the COVID-19 crisis. In: Data Science for COVID-19. Academic Press; 2022. p. 589-609.
  81. Poalelungi DG, Musat CL, Fulga A, Neagu M, Neagu AI, Piraianu AI, Fulga I. Advancing patient care: how artificial intelligence is transforming healthcare. J Pers Med. 2023;13(8):1214.
  82. Afriyie JK, Tawiah K, Pels WA, Addai-Henne S, Dwamena HA, Owiredu EO, et al. A supervised machine learning algorithm for detecting and predicting fraud in credit card transactions. Decis Anal J. 2023;6:100163.
  83. Hidayat AM, Choocharukul K. Passengers’ intentions to use public transport during the COVID-19 pandemic: a case study of Bangkok and Jakarta. Sustainability. 2023;15(6):5273.
  84. Ahmed AI, Kaiser A, Jayal G, Lesh N, Hasan MM, Rashid SF, Hasan MT. COVID-19 and the fear of other unknowns: challenges and lessons learned from a digital contact tracing activity in the Rohingya camps in Cox’s Bazar, Bangladesh. J Glob Health Rep. 2022;6:e2022021.
  85. Budd J, Miller BS, Manning EM, Lampos V, Zhuang M, Edelstein M, et al. Digital technologies in the public-health response to COVID-19. Nat Med. 2020;26(8):1183-92.
  86. Fontes C, Hohma E, Corrigan CC, Lütge C. AI-powered public surveillance systems: why we (might) need them and how we want them. Technol Soc. 2022;71:102137.
  87. Poongodi M, Malviya M, Hamdi M, Rauf HT, Kadry S, Thinnukool O. The recent technologies to curb the second-wave of COVID-19 pandemic. IEEE Access. 2021;9:97906-28.
  88. Kandati DR, Gadekallu TR. Genetic clustered federated learning for COVID-19 detection. Electronics. 2022;11(17):2714.
  89. Kandati DR, Gadekallu TR. Federated learning approach for early detection of chest lesion caused by COVID-19 infection using particle swarm optimization. Electronics. 2023;12(3):710.
  90. Norori N, Hu Q, Aellen FM, Faraci FD, Tzovara A. Addressing bias in big data and AI for health care: a call for open science. Patterns. 2021;2(10).
  91. Sipior JC. Considerations for development and use of AI in response to COVID-19. Int J Inf Manag. 2020;55:102170.
  92. Gieraerts C, Dangis A, Janssen L, Demeyere A, De Bruecker Y, De Brucker N, et al. Prognostic value and reproducibility of AI-assisted analysis of lung involvement in COVID-19 at low-dose submillisievert chest CT: sample size implications for clinical trials. Radiol Cardiothorac Imaging. 2020;2(5):e200441.
  93. Hamon R, Junklewitz H, Malgieri G, Hert P, Beslay L, Sanchez I. Impossible explanations? Beyond explainable AI in the GDPR from a COVID-19 use case scenario. In: Proceedings of the 2021 ACM Conference on Fairness, Accountability, and Transparency. 2021. p. 549-59.
  94. Ferrag MA, Shu L, Choo KKR. Fighting COVID-19 and future pandemics with the Internet of Things: security and privacy perspectives. IEEE/CAA J Autom Sin. 2021;8(9):1477-99.
  95. Kandati DR, Anusha S. Security and privacy in federated learning: a survey. Trends Comput Sci Inf Technol. 2023;8(2):029-37.
  96. Srivastava G, Kandati DR, Yenduri G, Hegde P, Gadekallu TR, Maddikunta PKR, et al. Federated learning enabled edge computing security for Internet of Medical Things: concepts, challenges and open issues. In: Security and Risk Analysis for Intelligent Edge Computing. Cham: Springer Int Publ; 2023. p. 67-89.
  97. Zou J, Schiebinger L. Ensuring that biomedical AI benefits diverse populations. EBioMedicine. 2021;67:103358. Available from: https://dx.doi.org/ 10.1016/j.ebiom.2021.103358.
  98. Xu Q, Xie W, Liao B, Hu C, Qin L, Yang Z, et al. Interpretability of clinical decision support systems based on artificial intelligence from technological and medical perspective: a systematic review. J Healthc Eng. 2023;2023.
  99. AL-Hashimi M, Hamdan A. Artificial intelligence and coronavirus COVID-19: applications, impact and future implications. In: The Importance of New Technologies and Entrepreneurship in Business Development: In the Context of Economic Diversity in Developing Countries. Springer Int Publ; 2021. p. 830-43.
  100. Wenderott K, Gambashidze N, Weigl M. Integration of artificial intelligence into sociotechnical work systems—effects of artificial intelligence solutions in medical imaging on clinical efficiency: protocol for a systematic literature review. JMIR Res Protoc. 2022;11(12):e40485 Available from: https://doi.org/10.2196/40485
  101. Jain R, Gupta M, Taneja S, Hemanth DJ. Deep learning based detection and analysis of COVID-19 on chest X-ray images. Appl Intell. 2021;51:1690-700.
  102. Dasaradharami Reddy K, Srivastava G, Zhu Y, Supriya Y, Yenduri G, Victor N, et al. Federated learning using the particle swarm optimization model for the early detection of COVID-19. In: International Conference on Neural Information Processing. Singapore: Springer Nature Singapore; 2023. p. 425-36.
  103. Singh K, Kaur N, Prabhu A. Combating COVID-19 crisis using artificial intelligence (AI) based approach: systematic review. Curr Top Med Chem. 2024;24(8):737-53.
  104. Qin C, Ma H, Hu M, Xu X, Ji C. Performance of artificial intelligence in predicting the prognosis of severe COVID-19: a systematic review and meta-analysis. Front Public Health. 2024;12:1371852. Available from: https://doi.org/10.3389/fpubh.2024.1371852
  105. Annan R, Qingge L. Artificial intelligence in COVID-19 research: a comprehensive survey of innovations, challenges, and future directions. Comput Sci Rev. 2025;57:100751

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?